Patents-Review.com
ClassID:

110920 ⎘

C12N2760/18234 - CPC Classification

Classification description:

ssRNA viruses negative-sense; Details; Paramyxoviridae; Henipavirus, e.g. hendra virus Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Recent Application in this class:
#1
20260130982
2026-05-14

METHODS FOR ASSEMBLING PROTEIN-CONJUGATED NANOCARRIER VACCINES

 #2
20250263442
2025-08-21

RECOMBINANT CEDAR VIRUS CHIMERAS

 #3
20250223572
2025-07-10

PARAMYXOVIRUS VIRUS-LIKE PARTICLES AS PROTEIN DELIVERY VEHICLES

 #4
20250127878
2025-04-24

Rapid Acting Vaccine Against Nipah Virus

 #5
20250090652
2025-03-20

HENIPAVIRUS VACCINE

 #6
20250064918
2025-02-27

NIPAH HENIPAVIRUS VIRUS REPLICON PARTICLES AND THEIR USE

 #7
20240408192
2024-12-12

MODIFIED PARAMYXOVIRIDAE ATTACHMENT GLYCOPROTEINS

 #8
20240382580
2024-11-21

MULTIVALENT VIRAL PARTICLES

 #9
20240358817
2024-10-31

STRUCTURES OF LANGYA VIRUS FUSION PROTEIN ECTODOMAIN AND IMMUNOGENIC COMPOSITIONS DERIVED THEREFROM

 #10
20230285591
2023-09-14

NIPAH VIRUS ENVELOPE PSEUDOTYPED LENTIVIRUSES AND METHODS OF THEIR USE

 #11
20230226167
2023-07-20

Henipavirus vaccine

 #12
20220267740
2022-08-25

Paramyxovirus virus-like particles as protein delivery vehicles

 #13
20220162567
2022-05-26

PARAMYXOVIRUS VIRUS-LIKE PARTICLES AS PROTEIN DELIVERY VEHICLES

 #14
20210299242
2021-09-30

Nipah virus immunogens and their use

 #15
20210252134
2021-08-19

VACCINES AGAINST NIPAH VIRUS, AND METHODS OF USING SAME

 #16
20200123623
2020-04-23

Immunogenic Cedar Virus compositions

 #17
20190351047
2019-11-21

Henipavirus vaccine

 #18
20190338253
2019-11-07

Paramyxovirus virus-like particles as protein delivery vehicles

 #19
20190125898
2019-05-02

Nipah virus envelope pseudotyped lentiviruses and methods of their use

 #20
20190083604
2019-03-21

HENDRA AND NIPAH VIRUS G GLYCOPROTEIN IMMUNOGENIC COMPOSITIONS

 #21
20190031721
2019-01-31

Soluble forms of Hendra and Nipah virus F glycoprotein and uses thereof

 #22
20190031719
2019-01-31

Soluble Forms of Hendra and Nipah Virus G Glycoprotein

 #23
20180326046
2018-11-15

Tunable vaccine platform against pathogens of the paramyxovirus family

 #24
20170175086
2017-06-22

Paramyxovirus virus-like particles as protein delivery vehicles

 #25
20170174728
2017-06-22

Soluble forms of Hendra and Nipah virus G glycoprotein

 #26
20170087242
2017-03-30

Hendra virus recombinant compositions and uses thereof

 #27
20160362755
2016-12-15

Cedar virus and methods of use

 #28
20150306208
2015-10-29

Soluble forms of hendra and nipah virus G glycoprotein

 #29
20150209422
2015-07-30

Immunization with rabies virus vector expressing foreign protein antigen

 #30
20150050242
2015-02-19

Nipah virus envelope pseudotyped lentiviruses and methods of their use

 #31
20140302076
2014-10-09

Immunogenic compositions and methods therefor

 #32
20120301479
2012-11-29

HENDRA VIRUS RECOMBINANT COMPOSITIONS AND USES THEREOF

 #33
20120263751
2012-10-18

Recombinant Measles Virus Useful as a Bivalent Vaccine Against Measles and Nipah Infections

 #34
20110311587
2011-12-22

Fusogenic virus-like particles and uses thereof

 #35
20110223172
2011-09-15

Soluble forms of Hendra and Nipah virus F glycoprotein and uses thereof

 #36
20100278862
2010-11-04

Nipah virus vaccines

 #37
20090041772
2009-02-12

Soluble forms of Hendra and Nipah virus G glycoprotein

 #38
20070150972
2007-06-28

Method for detecting Nipah virus and method for providing immunoprotection against Henipa viruses

 #39
20070031455
2007-02-08

Nipah virus vaccines

 #40
20060053501
2006-03-09

Method for detecting Nipah virus and method for providing immunoprotection against Henipa viruses